Quest
Augurex Inks Agreement With Quest Diagnostics to Validate and Sell Rheumatoid Arthritis Test
The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.
In Brief This Week: Quest Diagnostics, T2 Biosystems, Oncocyte, Myriad Genetics, More
News items for the week of Nov. 11, 2024
Top Five Articles on 360Dx Last Week: Roche Mpox Test Approved; Quest Diagnostics Revenues up; More
Last week, readers were most interested in a story about WHO approving Roche’s molecular mpox assay under the organization’s EUL procedure.
Quest Diagnostics Wins CDC Contracts for Avian Flu, Oropouche Testing
Quest has developed a multi-target molecular test for avian influenza A H5 virus that it plans to make available by the end of October.
CEO Jim Davis said the company is on track to close eight lab acquisition deals this year, though he added that it is now in an "integration and digestion" phase.
Oct 15, 2024
Oct 9, 2024
Jul 29, 2024
Jul 23, 2024